BR5402A not checked
Boryung Pharmaceutical Co., Ltd · BR5402B
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Schizophrenia
- Main trialPhase 2
- “The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia”In the company’s words, NCT06821945 on ClinicalTrials.gov
- Other names
- BR5402B
Other drugs for Schizophrenia
- CariprazineAbbVie · Phase 3
- EvenamideNewron Pharmaceuticals SPA · Phase 3
- LB-102LB Pharmaceuticals Inc. · Phase 3
- B2227Bostal Drug Delivery Co., Ltd · Phase 2/3
- Brexpiprazole for ER injectionBostal Drug Delivery Co., Ltd · Phase 2/3
- LYBALVIAlkermes, Inc. · Phase 3
Coming up1
- May 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | May 2027 | A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026